Subscribe 600$/product give away!
Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     


  1. Patient Information
  2. Inform Patients:

Patient Information 

If patients have had neuraxial anesthesia or spinal puncture, and particularly, if they are taking
concomitant NSAIDs, platelet inhibitors, or other anticoagulants, advise them to watch for
signs and symptoms of spinal or epidural hematoma, such as tingling, numbness (especially
in the lower limbs) and muscular weakness. Instruct the patient to seek immediate medical
attention if any of these symptoms occur.

Inform Patients: 

  • of the instructions for injecting Enoxaparin Sodium Injection if they continue Enoxaparin Sodium Injection therapy after discharge from the hospital.
  • that it might take them longer to stop bleeding.
  • that they may bruise and/or bleed more easily when they use Enoxaparin Sodium Injection.
  • that they should report any unusual bleeding, bruising, or signs of thrombocytopenia (such as a rash of dark red spots under the skin) to their physician [see Warnings and Precautions (5.1,5.5)].
  • that risks are associated with the use of benzyl alcohol, a preservative in Enoxaparin Sodium Injection multidose vials, in neonates, infants, and pregnant women.
  • to tell their physicians and dentists they are taking Enoxaparin Sodium Injection and/or any other product known to affect bleeding before any surgery is scheduled and before any new drug is taken [see Warnings and Precautions (5.1,5.3)].
  • to tell their physicians and dentists of all medications they are taking, including those obtained without a prescription, such as aspirin or other NSAID s [see Drug Interactions (7)].

Amphastar Pharmaceuticals, Inc.
Rancho Cucamonga, CA 91730 U.S.A.
Rev. 12/18


Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: